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The α7β1 integrin is a transmembrane protein in skeletal muscle which serves as a focal 
adhesion at costameres of skeletal muscle, providing a critical link between the actin cytoskeleton inside 
the cell with laminin in the basement membrane of the extracellular matrix.  Previous research has 
demonstrated that overexpression of the α7 integrin accelerates the muscle growth response to 
eccentric exercise compared to wild type controls. PURPOSE: The goal of this project was to elucidate a 
role for the α7 integrin as a mechanotransducer and intrinsic regulator of hypertrophic signaling in 
response to mechanical strain. METHODS: Primary myoblasts extracted from wild type (WT) mice were 
developed into myotubes in culture to determine the hypertrophic signaling response to mechanical 
strain.  Primary myoblasts from α7 knockout (KO) mice were used as controls for these experiments.  
Further experimentation employed transient transfection of WT myoblasts with a α7 integrin plasmid 
transgene containing a muscle creatine kinase and myosin heavy chain promoter (MHCK7) to induce α7 
integrin expression.  Transfected myotubes were subjected to overnight incubations in wortmannin with 
the goal of inhibiting any potential autocrine-mediated growth factor signaling pathway through PI3K 
inhibition.    RESULTS:  Lack of α7 integrin was verified in KO cells.  In WT, mechanical strain increased α7 
integrin protein at 3 PS on both substrates compared to control (P<0.05; 1.8-fold collagen, 3-fold 
laminin).  Phosphorylation of p70 S6K was increased 5-fold only on laminin at 3 PS (P<0.05). In contrast, 
no change in p70 S6K phosphorylation was observed in KO cells on either substrate.  Interestingly, mTOR 
phosphorylation was not significantly altered in WT myotubes, and no change was observed in KO 
myotubes in response to strain.  Transgenic overexpression of the α7 integrin in myotubes resulted in a 
trend toward increased activation of hypertrophic signaling compared to controls, which did not reach 
statistical significance.  CONCLUSION: This study provides evidence that the α7 integrin is upregulated in 
response to mechanical strain and is inconclusive on whether the α7 integrin is an intrinsic regulator of 
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INTRODUCTION AND LITERATURE REVIEW 
A) Purpose  
 Myofibrillar protein synthesis in skeletal muscle is greatly enhanced by the presence of 
nutrients, such as amino acids, and insulin/insulin-like growth factor receptor activation (Goldspink 
2002; Hornberger, 2006).  Growth factor induced stimulation through the Insulin/IGF-1 receptor is the 
most investigated, and nutrient stimulated hypertrophic signaling also has been greatly explored.  While 
there is suggestion in the literature that myofibrillar synthesis can occur in muscle in an IGF-1 receptor-
independent manner in response to mechanical strain, the mechanisms responsible for this event in 
muscle are not known.  In addition, the primary stimulus for increased muscle growth in response to 
eccentric contractions has not been identified.    
Integrins link the cell cytoskeleton with the extracellular matrix (ECM), thereby creating an 
intrinsic system capable of transmitting mechanical forces between the outside and inside of a cell 
(Roca-Cusachs, 2012).  Overexpression of the α7 integrin in muscle using a transgenic animal approach 
has been used to test the hypothesis that this protein is important for muscle growth following exercise, 
including facilitation of fiber cross sectional area, myofibrillar content, and increased activation of 
hypertrophic signaling compared to wild type controls (Lueders, 2012; Zou, 2012).  The purpose of this 
study was to determine the extent to which the α7 integrin directly regulates the growth response to 
eccentric exercise.   
B) Mechanosensing of cells 
All living things possess the ability to respond to stimuli, and thus each individual cell possesses 
the necessary machinery to sense stimuli.  The cellular response to mechanical stimulation has been 
well studied.  Some of the observed responses to mechanical strain include increases in size due to 
growth, increases or decreases in cell proliferation, changes in morphology, secretion of factors, and 
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alterations in alignment (Adams, 2004; Duncan, 1995; Neidlinger-Wilke, 2002; Pennisi, 2011; Wilson, 
1993). 
Osteoblasts and osteocytes in bone are highly responsive to loading, and this event can 
subsequently allow for an increase in bone formation (Duncan, 1995).  Both vascular smooth muscle and 
skeletal muscle have been shown to release growth factors in response to strain, which cause growth in 
an autocrine fashion (Adams, 2004; Wilson, 1993).  Both fibroblasts and myoblasts have been shown to 
align perpendicularly to strain, and in the presence of differentiation media, myoblasts form myotubes 
aligned perpendicularly to the axis of strain in vitro (Neidlinger-Wilke, 2002; Pennisi, 2011). 
 
Figure 1: Myoblasts align perpendicularly to the axis of strain, and differentiate perpendicularly to strain as well 
(Pennisi, 2011). 
 
C) The α7β1 Integrin 
 Integrins are transmembrane protein heterodimers consisting of α and β subunits.  Integrins 
connect the cytoskeleton inside of the cell, with the extracellular matrix outside of the cell.  They are 
found in various cell types to be sensors of external stimulation and transmit perceived stimuli as 




Figure 2: Diagram of integrin mediated adhesion of the cell cytoskeleton to the extracellular matrix (Used with 
permission, MD Boppart) 
 
Eighteen different α subunits and 8 different β units are expressed by a variety of mammalian 
cell types, resulting in the potential to form numerous unique integrin heterodimers.  The α7β1 integrin 
heterodimer, which is highly expressed in skeletal muscle, primarily at the neuromuscular and 
myotendinous junctions, acts to stabilize Z bands.  The α7 integrin subunit binds laminin in the basal 
lamina, and the β1 subunit binds the actin cytoskeleton within the muscle fiber (Bao, 1993; Boppart, 
2008).  The splicing of α7 transcripts can result in cytoplasmic domain isoforms α7A or α7B, and 
extracellular domain isoforms BX1 and BX2.  The predominant heterodimer is α7BX2 for both 
proliferating myoblasts, and adult skeletal muscle (Burkin, 1999).  In the process of differentiation 
however, myoblasts predominantly express the extracellular splice variant X1, switching the expression 
to splice variant X2 once muscle fibers are mature (Schober, 2000).  Both isoforms α7A and α7B are 
expressed in skeletal muscle as well as in terminally differentiated myotubes in vitro.  However 
myoblasts express only the α7B isoform and do not begin expressing the α7A isoform until 




Figure 3: The α7β1 integrin acts to stabilize skeletal muscle by connecting laminin in the extracellular matrix with 
the actin cytoskeleton at z-bands in skeletal muscle (Used with permission, MD Boppart). 
 
The α7 integrin plays an important structural role in skeletal muscle, providing stabilization of 
the fibers within the extracellular matrix.  The expression of the α7 integrin is important for 
intramuscular health and prevention of damage during contraction (Boppart, 2006; Boppart, 2008).  It 
plays a particularly important role in maintaining myotendinous junction integrity and is highly 
expressed both during development and in adult skeletal muscle.  Additionally, the α7 integrin is 
important for the formation and proper structure of the neuromuscular junctions.  Early neuromuscular 
junction formation is characterized by clustering of acetylcholine receptors, which is induced by the 




Figure 4: The α7 integrin is highly expressed at the neuromuscular and myotendinous junctions in skeletal muscle 
(Burkin, 1999). 
 
 The α7 integrin allows for a compensatory role in muscular diseases where the structural 
integrity is compromised such as with muscular dystrophy, and the lack of the α7 integrin results in an 
increased accumulation of damage in muscle resulting in a similar pathology as muscular dystrophy 
(Mayer, 1997).  In both human patients, and experimental mdx mice, α7 integrin protein is upregulated 
to compensate for the lack of transmembrane adhesions between the muscle fiber and extracellular 
matrix (Liu, 2011).  In mdx mice, which serves as a model for Duchene Muscular Dystrophy, there is 
restoration in functionality and protection against sarcolemmal damage when bred with α7 integrin 
overexpressing transgenic mice so long as there is an accompanying overexpression of the β1 portion of 
the heterodimer due to increases in functional α7 integrin at the cell membrane (Liu, 2011). Mice lacking 
expression of the α7 integrin develop a progressive dystrophic phenotype, characterized the presence 
of damage and inflammation in muscle which is especially pronounced at the myotendinous junction 




Figure 5: Tenascin- C staining indicates increased damage in a7 integrin knockout (g) myotendinous junction of the 
tibialis anterior muscle, as compared to wild type controls (h) (Mayer, 1997). 
 
 In addition to the structural contribution of the α7 integrin to healthy muscle, there is evidence 
to suggest the α7 integrin plays a role in regulating hypertrophic signaling.  The literature provides some 
conflicting results as to whether the α7 integrin enhances or negatively regulates the hypertrophic 
signaling response.  In one study, activation of stress activated protein kinases c-jun NH2-terminal kinase 
( JNK) and p38 were reduced in transgenic mice overexpressing the  α7 integrin following 30 minutes of 
downhill running as compared to WT controls (Boppart, 2006).  Additionally, activation of hypertrophic 
signaling molecules mTOR and p70 S6 Kinase was reduced (Boppart, 2006).  More recent studies have 
since demonstrated increases in whole muscle and fiber cross sectional area, force output, and 
activation of hypertrophic signaling in transgenic mice overexpressing the α7 integrin following both 





Figure 6:  Increases in muscular hypertrophy and increased activation of hypertrophic signaling molecules are 
observed in transgenic α7 integrin overexpressing mice as compared to wild type controls (Zou, 2012). 
 
D) The Hypertrophic Signaling Pathway 
Hypertrophy of muscle fibers can occur due to increased cytosolic content, such as increased 
water and glycogen, or due to increased accumulated contractile myofibrillar protein (Glass, 2005).  Net 
protein accumulation can only occur if formation of contractile proteins occurs at a rate that exceeds 
degradation.  Hypertrophic signaling refers to the signaling cascade that transmits extracellular signals 
into an increase in translational efficiency in the process of protein synthesis (Kimball, 2002; Goldspink, 
1977).  The four steps of protein translation include:  initiation, elongation, translocation and 
termination.  These steps are facilitated by ribosomes which are composed of a large 60S and small 40S 
subunit (Mahoney, 2009).  In the step of initiation, initiation factors allow for the association of both 
mRNA and tRNA with the ribosome (Berg, 2002).  In the step of elongation, mRNA moves through the 
ribosome, adding amino acids in a step wise fashion which elongates the peptide.    Translocation is the 
step of translation in which tRNA moves to a different site on the ribosome, allowing for additional tRNA 
to bind the ribosome while the original mRNA continues to be translated until a stop codon is reached.  
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Termination is the final step of translation in which a stop codon is reached in the mRNA sequence, and 
the amino acid chain is hydrolyzed, freeing it from the ribosome (Berg, 2002).  
The steps of translation that can potentially be regulated are initiation, elongation, and 
termination, and hypertrophic signaling in skeletal muscle primarily affects initiation (Kimball, 2002).  
Initiation is the rate limiting step of translation and requires a series of eukaryotic initiation factors 
(eIFs), which assemble together with the 60S and 40S subunits of the ribosome as well as tRNA. 
Initiation factors eIF1A, eIF1, eIF3, and eIF5 form the pre-initiation complex (PIC) which binds the 40S 
ribosomal subunit.   Three initiation factors eIF4E, eIF4G, and eIF4A form a complex called eIF4F which 
bind the cap at the 5’ end of mRNA, facilitating binding of mRNA with the pre-initiation complex on the 
ribosome.  Finally, eIF2 is freed from the complex through hydrolysis of GTP which is a process 
facilitated by eIF2B.  The release of eIF2 and other initiation factors from the complex allows for the 
binding of the 40S and 60S subunits together to form the 80S ribosome.  Phosphorylation and 
dephosphorylation is the regulatory mechanism for many of the proteins involved in translation.  For 
example, eIF4F formation is a step which can be regulated by the hypertrophic signaling cascade.  eIF4E-
binding proteins (4E-BPs) bind eIF4E, and phosphorylation of these binding proteins releases eIF4E 
allowing its involvement in the formation of eIF4F  (Mahoney, 2009).   
Three distinct pathways have been identified (growth factor, nutrient, and mechanostimulation) 
all of which lead to increased translational efficiency.  It is thought that the central hypertrophic 
signaling molecule at which these three distinct pathways conjoin is the mammalian target of rapamycin 
(mTOR).  mTOR is made of two complexes, mTORC1 and mTORC2, with mTORC1 being shown to directly 
phosphorylate 4E-BP1, allowing for the formation of eIF4F, and also phosphorylate S6 Kinase via p70 S6 
kinase which together allow for hypertrophy through the regulation of ribosomal biogenesis and protein 
synthesis (Mahoney, 2009).  In growth factor signaling, mTOR is activated by phosphorylation through 
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AKT, however the precise mechanisms for the activation of mTOR via nutrient and mechanical stimuli 
are unknown. 
 
Figure 7: Diagram of the hypertrophic signaling pathway shows three distinct and independent pathways involving 
nutrient, growth factor, and mechanostimulated activation of protein synthesis (Hornbeger, 2011).   
 
The most well described pathway is growth factor signaling which begins with the insulin/IGF-1 
receptor, and signals through AKT, which in addition to its involvement in protein synthesis, plays a role 
in regulating protein degradation and glucose uptake.  The amino acid, or nutrient stimulated 
hypertrophic signaling pathway is less understood, but this pathway appears to be dependent on mTOR 
and independent of AKT(Anthony, 2000; Wang 1998).  The third and least understood of these pathways 
is the mechanically stimulated pathway, in which a mechanotransducer transmits stress signals from 
outside of the cell through a signaling cascade to increase translation initiation efficiency.  One of the 
pioneer studies which identified mechanical stimulation alone is sufficient to stimulate an increased 
accumulation of myofibrillar protein was performed by Vandenburg et al. in 1979.  In this study, 
myotube cultures were stretched on frames in the absence of growth factor and amino acid uptake and 
total protein accumulation were measured 72 hours after the application of mechanical strain.  The 
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results showed a marked increase in total protein in strained myotubes as compared to unstrained 
controls.   
 
Figure 8: Mechanical stimulation of cultured myotubes in the absence of growth factors results in hypertrophy and 
increased total protein compared to unstrained controls (Vandenburg, 1979). 
 
 
The use of pharmacological inhibitors is an important tool for study into the mechanisms 
involved in stimulating the hypertrophic signaling pathway.  Wortmannin is a fungal inhibitor of 
phosphoinositide 3-kinase (PI3K), a signaling protein that transmits the growth factor signal from the 
receptor to AKT.  The use of wortmannin is important in establishing the mechanism by which 
translation is initiated, by eliminating the ability for AKT to phosphorylate and activate mTOR.  In 
response to mechanical loading, muscle specific forms of IGF-1, also known as MGF, can be released 
from the tissue, which can activate growth factor stimulated hypertrophy via autocrine and paracrine 
signaling (Adams, 2004; Goldspink, 2002).  Inhibition of paracrine and autocrine growth factor signaling 
is imperative in determining the extent to which mechanical strain can stimulate hypertrophic signaling 
through an intrinsic mechanism.  Another inhibitor, rapamycin, acts further downstream, inhibiting the 
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activation of mTOR.  Similar to wortmannin’s use in implicating AKT involvement in signaling, rapamycin 
is a useful tool to implicate the involvement of mTOR in hypertrophic signaling.  Miyazaki et al. 
demonstrated the use of these tools nicely in a study published in 2011.  In this study,  both 
wortmannin, and rapamycin inhibited activation of p70 S6 Kinase demonstrating the necessity of both 
mTOR and AKT in growth factor induced hypertrophic signaling.  In a second experiment, Miyazaki used 
synergistic ablation of the gastrocnemius and soleus to cause an overload of the plantaris muscle to 
model load induced hypertrophy.  Wortmannin and rapamycin were used to determine whether AKT 
and mTOR were necessary for the hypertrophic signaling response to mechanical overload.  Consistent 
with other studies, he found that activation of p70 S6 Kinase (Thr389) by mechanical loading was AKT 
independent, and mTOR dependent.  Interestingly, this study demonstrated a partial blunting of p70 S6 
Kinase (Thr421/424) in response to overload in the presence of rapamycin. Similar results have been 
obtained using other approaches (Hornberger, 2004).   
 
Figure 9: Injection of insulin alone results in the activation of p70 S6 Kinase (Thr389 & Thr421/Ser424), but this 
response is inhibited by both rapamycin and wortmannin.  Overload of the plantaris muscle due to synergistic 
ablation results in activation of p70 S6 Kinase (Thr389 & Thr421/Ser424) with or without PI3K inhibition through 
wortmannin.  Only p70 S6 Kinase (Thr389) activation due to overload is completely blocked with rapamycin, but 








E) Hypothesis  
We hypothesize that the α7 integrin is a mechanotransducer and an intrinsic regulator of 
hypertrophic signaling.  A series of experiments using myotubes in vitro will be employed to test the 
following specific hypotheses:  
1. The presence of the α7 integrin is necessary for phosphorylation and activation of mTOR and 
p70 S6K in response to mechanical strain. 
2. Adhesion of the α7 integrin to laminin, a specific ligand for the α7 integrin, provides optimal 
myotube adhesion and α7 integrin-mediated increases in hypertrophic signaling. 
3. The α7 integrin can increase activation of mTOR and p70 S6K in a manner independent of 
growth factor signaling. 
F)  Formulating the Experimental Design 
 In attempting to implicate mechanotransduction as the mechanism for the increased 
hypertrophy of skeletal muscle observed in transgenic α7 overexpressing mice using in vitro methods, a 
model for mechanical stimulation of myotubes was required. Hornberger et al. previously optimized a 
strain protocol for use with C2C12 cells using the Flexcell System created by Flexcell International 
(Hornberger, 2004).  In this experiment, C2C12 myoblasts were differentiated into myotubes on a 
collagen I treated bioflex membrane and strained uniaxially or equibiaxially at 15% strain for 10, or 60 
minutes, resulting in significant increases in phospho p70 S6 Kinase (Thr 389) only with equibiaxial 
strain.  Based on this information, myoblasts extracted from α7 integrin knockout mice were 
differentiated into myotubes, and in additional experiments, transient transfection was used to 
overexpress the α7 integrin using plasmid DNA.  Current research methods have been unable to 
transfect terminally differentiated myotubes using liposome mediated transfection reagents, and 
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additional work has demonstrated higher efficiencies with the transfection of cells in suspension 
(Escobedo, 2003; Neuhuber, 2002).  Using this information the transfection protocol developed for 
experiments performed in this thesis followed the established method of transfecting myoblasts during 
plating.  The lack of a reporter in the plasmid vector brought the obstacle of determining whether 
transfection was successful.  Previous studies provided the observation that the rat α7 integrin which is 
coded in the plasmid transgene, is cleaved differently in western blotting than the resident mouse 
integrin, which results in an additional 70 kDa band which was used to identify whether or not 
transfection was successful (Liu et al. 2011). 
 
Figure 10: Cleavage of rat α7 integrin occurs during western blotting, which results in a 70 kDa band from muscles 
with transgenic overexpression of the α7 integrin.  Due to the lack of a reporter in the vector, this information was 

























A) Cell culture  
C2C12 Cells were grown in 50/50 DMEM/F12 (Cellgro #10-092-CV), 20% Fetal Bovine Serum 
(FBS) (Atlanta Biologicals #s11150 – Lot B1011) and 1% Penicillin/Streptomycin (Cellgro #30-002-CI).   
Primary Cells were grown in 50/50 DMEM/F12, 20% FBS 1% Penicillin/Streptomycin, with .01% 
recombinant Fibroblast Growth Factor (rFGF) (Invitrogen #PHG0024).  Cells were thawed and plated on 
plastic to eliminate cells which died during freezing or thawing.  After 48 hours they were detached with 
trypsin, counted, and  plated (~150,000 cells/well) on a 6 well Bioflex silicone membrane, from Flexcell 
International.  The membranes were treated with collagen I (Flexcell International #BF-3001C), or 
laminin (Flexcell International #BF-3001L) substrate.  Growth media was replaced by differentiation 
media consisting of high glucose DMEM (Cellgro #10-017-CV) with 2% horse serum (Life Technologies 
#26050-088), and 1% penicillin/streptomycin and added to myoblasts when ~70% confluence was 
obtained.  
 




When large multinucleated myotubes were more abundant than remaining myoblasts, the 
media was replaced with growth factor depleted stretch media consisting of high glucose DMEM and 1% 
penicillin/streptomycin.  For PI3K inhibition experiments, 10 μM wortmannin (EMD Millipore #681675) 
was added to the stretch media. 
B) Transfection 
Ampicillin resistant bacteria (DH5α Amp-R) containing either plasmid DNA encoding for rat α7 
integrin with a myosin heavy chain and creatine kinase promoter (pMHCK-BX2) or a vector (MHCK-CAT) 
was streaked onto Luria Broth (LB) + Ampicillin (AP) treated agar plates, and grown overnight at 37o
Transient transfection using liposome mediated delivery reagents was performed using .5 µg of 
DNA with either the α7 plasmid or the empty vector as a control.  In order to find a working reagent, an 
initial experiment using FuGENE® HD (Promega #E2311), Effectene (QIAGEN # 301425), or Lipofectamine 
(Life Technologies # 18324010) was performed.  For this test, cells were suspended in growth media and 
exposed to the DNA-transfection reagent mix for 24 hours while adhering to the Bioflex membrane.  
After deciding to use FuGENE® HD as the transfection reagent, additional experiments were performed 
using this reagent only. 
C.  
The following afternoon, single colonies were isolated and placed into 50 mL Falcon tubes containing 
5ml of LB with 100 mg/ml AP.  Plasmid DNA was extracted the following morning using QIAprep Spin 
Miniprep Kit (QIAGEN #27104).  
C) Mechanical Strain 
Mechanical strain was applied to myotubes after an 18 h incubation period in growth factor 
depleted stretch media with wortmannin, or media only.  Strain was applied to the cells equibiaxially by 
deforming the silicone membrane of the Bioflex plate 18% using the Flexcell System (FX-4000) 
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(Hornberger 2004, 2009). The strain was applied in a triangle waveform with a 50% duty cycle, for 1 
second, with 1 second of rest. This was repeated for 20 minutes.   
 
Figure 12: Diagram of cell culture methods.  Myoblasts were plated on bioflex membranes, differentiated into 
myotubes, and strained using the Flexcell system.  When applicable, transfection was performed on suspended 
cells as they attached to the bioflex membrane.   
 
D) Myotube Harvest 
Myotubes were removed from the Bioflex dish using a cell scraper immediately post strain (0h) 
or three hours post strain (3h).  Unstrained plates (rest) were used as controls.  Cells were scraped in the 
stretch media (2 wells = 1 n), transferred to 15 mL falcon tubes, which were then placed on ice until they 
were spun at 450 g for 5 minutes.  The media was aspirated, the pellet resuspended in 1 mL of cold 1x 
PBS, and the suspension was transferred to a 1.5 mL eppendorf tube and spun at 14,000 rpm at 2oC.  
The 1x PBS was aspirated off, and the pellet was frozen at -80o
E) Protein Extraction 
C until protein was extracted.   
After harvesting the myotubes from the Bioflex dishes, protein was extracted in RIPA Buffer 
(Tris-Base, NaCL, NP-40, Sodium Deoxycholate, SDS Powder, PMSF, PhosSTOP (Roche #04-906-845-001) 
[1 pill/10 mL] and Complete Mini (Roche #04-693-124-001) [1 pill/10 mL]) on ice.  Pellets were re-
suspended in RIPA buffer and agitated for 45 minutes.  The tubes were spun at 14,000 RPM, and 
supernatant containing the proteins of interest were collected.  Remaining Pellets were re-suspended in 
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RIPA buffer and agitated for an additional 30 minutes.  After a second spin at 14,000rpm, supernatant 
was collected and added to the supernatant collected after the first spin. 
F) Western Blot 
After protein extraction, the concentrations of protein were determined by Bradford assay.  
Protein was diluted with ddH2
Protein was transferred to a nitrocellulose (GE Healthcare #RPN303D) membrane at 100 volts 
for 30 minutes in cold transfer buffer.   The nitrocellulose membranes with protein run from reducing 
conditions were cut into 4 pieces.  A cut above the 37 kDa ladder was made to probe for phosphorylated 
(Cell Signaling #4856) and total S6 (Cell Signaling #2217).  A cut was made just above the 50 kDa ladder, 
and this piece was used to probe for α-tubulin (Cell Signaling #2144) which was used as a loading 
control.  Another cut was made just above the 100 kDA ladder;  the next piece was used to probe for 
Phospho-p70 S6 Kinase (Thr389) (Cell Signaling #9205) and Phospho-p70 S6 Kinase (Thr421/Ser424) (Cell 
Signaling #9204); with the remaining top piece used to probe for phosphorylated (Cell Signaling #2971) 
and total mTOR (Cell Signaling #2972).  A separate gel was used to probe for α7 integrin (CDB347), which 
was re-probed for β-actin (Cell Signaling #4967) as a loading control. A separate gel was used to probe 
for phosphorylation of AKT (Cell Signaling #587F11) and total AKT (Cell Signaling #9272).   
O accordingly to reach 30ug of protein.  Laemmli buffer and DTT was 
added to samples (reducing conditions), and boiled for 5 minutes when probing for signaling proteins.  
When probing for α7 integrin, Laemmli buffer without DTT was used, and the samples were not boiled 
(non-reducing conditions).  SDS-page gels with 8% acrylamide running and 3.5% acrylamide stacking was 
used for both signaling proteins and α7 integrin.  Precision Plus Protein Standard (BIO-RAD #161-0374) 
was loaded into one of the wells of the gel along with the samples and 100 volts were applied for 30 
minutes.  The voltage was then adjusted to 200 volts and gels were run until the 25 kDa band reached 
the bottom.   
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Membranes were blocked in the same solution as the primary antibody (either 5% nonfat dry 
milk [NFDM], or 5% Bovine Serum Albumin [BSA]). Primary antibodies were mixed in a concentration of 
1:1000, all in 5% BSA except for the α7 antibody and α-tubulin which were mixed in 5% NFDM.  All 
membranes except the membrane for α7 integrin were blocked for 1 hour, probed overnight, and 
incubated for 1 hour in 1:2000 secondary antibody conjugated with horse radish peroxidase (HRP) in 2% 
NFDM.   The α7 integrin was blocked overnight, probed in the primary antibody for 1 hour, and the 
secondary for 1 hour at a concentration of 1:10000.  After a series of washes in TBS-Tween, blots were 
incubated in SuperSignal West Dura Extended Duration Substrate (Thermo Scientific #34076) solution 
for 5 minutes in the dark, and imaged using the BIORAD Chemidoc XRS.  Images were processed and 
quantified using Quantity One software.  In order to re-probe membranes for proteins of the same size 
after imaging, ECL solution was rinsed off using 1x TBS-Tween, and incubated in stripping buffer for 20 
minutes.  The stripping buffer was then washed off 3x in 1x PBS 
 
 
Figure 13: Diagram of protein analysis.  After strain, myotubes were scraped from the bioflex membrane and 
cytoplasmic proteins were extracted using RIPA buffer.  Proteins were separated using gel electrophoresis and 
transferred to a nitrocellulose membrane.  Antibodies were used to detect the protein of interest and imaged 
using the Chemidoc XRS.  Protein was quantified using Quantity One software. 
 
G) Immunocytochemistry  
Immunocytochemistry for α7 integrin was performed after an overnight incubation in laminin-
111 (Invitrogen  # 23017-015) on myotubes cultured on glass chamber slides.  Samples were fixed for 30 
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minutes in 4% paraformaldehyde and blocked for 1 hour in 10% horse serum (HS).  Samples were 
incubated for 1 hour in the primary antibody (CDB347) which was prepared at 1:500 in 1% HS.  The 
secondary antibody (FITC-anti rabbit 1:250 in 1% HS) incubation was also 1 hour. 
H) List of Materials 
Material Company Product # 
50/50 DMEM/F12  Cellgro 10-092-CV 
Fetal Bovine Serum  Atlanta Biologicals 
s11150 – Lot 
B1011 
Penicillin/Streptomycin Cellgro 30-002-CI 
rFGF Invitrogen PHG0024 
Collagen I Bioflex Plate Flexcell International BF-3001C 
Laminin Bioflex Plate Flexcell International BF-3001L 
High Glucose DMEM  Cellgro 10-017-CV 
Horse Serum  Life Technologies 26050-088 
wortmannin Emd Millipore 681675 
QIAprep Spin Miniprep Kit QIAGEN 27104 
FuGENE® HD  Promega E2311 
Effectene QIAGEN 301425 
Lipofectamine Life Technologies 18324010 
PhosSTOP Roche 04-906-845-001 
Complete Mini Roche 04-693-124-001 
Nitrocellulose Hybond ECL GE Healthcare RPN303D 
Precision Plus Protein Standard BIO-RAD 161-0374 
Phosphorylated S6 Cell Signaling 4856 
Total S6 Cell Signaling 2217 
α-tubulin Cell Signaling 2144 
Phosphor-p70 S6 Kinase (Thr389)  Cell Signaling 9205 
Phosphor-p70 S6 Kinase (Thr421/Ser424)  Cell Signaling 9204 
Phosphorylated mTOR Cell Signaling 2971 
Total mTOR Cell Signaling 2972 
α7 integrin CDB347     
β-actin Cell Signaling 4967 
Phosphorylated AKT Cell Signaling 587F11 
Total AKT Cell Signaling 9272 
SuperSignal West Dura Extended Duration Substrate  Thermo Scientific 34076 




I) Experimental design 
1) Wild type vs. Knockout Primary Cells on Collagen-I or Laminin Substrate 
The purpose of this experiment was to determine the effect of substrate (collagen and laminin) 
on α7 integrin activation and the resulting signaling response.  Primary cells extracted from wild type 
(WT) mice or α7 integrin knockout (KO) mice were used.  Protein amount and activity (α7 integrin, p70 
S6K phosphorylation, total p70 S6K, mTOR phosphorylation, and total mTOR) were analyzed via western 
blot.  The groups are as follows: 
Cell Type Substrate Rest 0h 3h 
WT Collagen I N=6 N=6 N=6 
WT Laminin N=4 N=4 N=4 
KO Collagen I N=6 N=4 N=4 
KO Laminin N=4 N=4 N=4 
 
2) Laminin-111 Treatment of myotubes 
In this experiment myotubes differentiated from C2C12 cells on Collagen I substrate were 
subjected to an overnight incubation in Laminin 111, in a high concentration (100nM) and a low 
concentration (50 nM).  The limitation of this experiment was detachment of the tubes from the Flexcell 
membrane at some point during strain, particularly those tubes which had experienced an overnight 
incubation of laminin 111.  Cells were harvested 3 hours after strain.  Protein amount and activity (α7 
integrin, p70 S6K phosphorylation, total p70 S6K, mTOR phosphorylation, and total mTOR) were 
analyzed via western blot.  The groups are as follows: 
Rest no 
Lam 111 














An additional experiment using laminin-111 was performed for immunocytochemistry (ICC) 
analysis.  C2C12 cells were seeded onto 4 well glass chamber slides and differentiated into myotubes.  
Cells were then incubated overnight in laminin-111 (0nM, 25nM, 50nM, 100nM, and 200nM).  ICC was 
then performed for α7 integrin and imaged using a fluorescence microscope.   
3) Transfection optimization 
The purpose of this experiment was to determine the optimal liposome mediated transfection 
reagent for the delivery of the pMHCK-bx2 plasmid into myoblasts coding for overexpression of the rat 
α7 integrin.  Plasmid DNA (0.5 µg) was delivered to each well of the 6 well bioflex dish.  After 
differentiation, myotubes were strained or left as controls, and harvested 3h post strain.  Protein 
amount and activity (α7 integrin, p70 S6K phosphorylation, total p70 S6K, S6 phosphorylation, total S6, 
mTOR phosphorylation, total mTOR, α-tubulin, and β-actin) was analyzed via western blot.  The 
limitation to this experiment was the death of all the cells which were exposed to the Effectene 
transfection reagent. Groups are as follows: 
 FuGENE® HD  Lipofectamine Effectene 
Rest Vector (control) N=2 N=2 N/A 
Rest Plasmid N=2 N=2 N/A 
Stretch Vector N=2 N=2 N/A 
Stretch Plasmid N=2 N=2 N/A 
 
4) PI3K Inhibition (Wortmannin) on Strained, and Unstrained Transfected Myotubes 
In this experiment Primary Myoblasts were transfected with pMHCK-BX2 (Plasmid), or MHCK-
CAT (Vector), and either incubated over night with Wortmannin (10µM) or left as a control.  Half of the 
samples were subjected to mechanical strain, and the other half were left as controls.  Cells were 
harvested 3h post strain.  Protein amount and activity was analyzed via western blot (α7 integrin, p70 
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S6K phosphorylation, total p70 S6K, S6 phosphorylation, total S6, mTOR phosphorylation, total mTOR, α-
tubulin, β-actin, AKT phosphorylation and total AKT).  The groups are as follows:  
 10µM Wortmannin No Wortmannin 
Rest Vector N=3 N=3 
Rest Plasmid N=3 N=3 
Strain Vector N=3 N=3 
Strain Plasmid N=3 N=3 
 
5) PI3K Inhibition (Wortmannin) and Strain on Transfected Myotubes 
In this experiment Primary Myoblasts were transfected with pMHCK-BX2 (Plasmid), or MHCK-
CAT (Vector), and either incubated over night with Wortmannin (10µM) or left as a control.  All samples 
were subjected to mechanical strain.  Cells were harvested 3h post strain.  Protein amount and activity 
was analyzed via western blot (α7 integrin, p70 S6K phosphorylation, total p70 S6K, S6 phosphorylation, 
total S6, mTOR phosphorylation, total mTOR, α-tubulin, β-actin, AKT phosphorylation and total AKT).  
The groups are as follows:  
 10µM Wortmannin No Wortmannin 
Vector N=3 N=6 











A) KO vs. WT Myoblasts differentiation and Myotube Phenotype 
 
 In the search for an appropriate experimental model to implicate the α7 integrin as a 
mechanotransducer, the first step was to form myotubes in the wells of the Bioflex culture plates.  
Myotubes are formed in culture by terminal differentiation and fusion of myoblasts, which have been 
extracted from muscles (Rudnicki, 2005).  Myoblasts which were extracted from both α7 Integrin 
knockout (KO) and wild type (WT) mice by a previous researcher in the Molecular Muscle Physiology lab 
were used for this first attempt. 
 The 6 well Bioflex culture plates from Flexcell International can be purchased with a substrate 
coating.  Because cells will not attach to the untreated silicone membranes, both collagen I-treated, and 
laminin-treated dishes were used in the first wave of experiments for this project.  We also 
hypothesized that myotubes expressing high levels of the α7 integrin would preferentially adhere to 
laminin, the α7 integrin binding partner, ultimately allowing for optimal transmission of force in an 
outside-in manner. 
 As seen in Figure 14, myotubes formed from WT myoblasts formed long healthy tubes, while 
myotubes formed from KO myoblasts formed short tubes with unusual morphology.  The unusual 




Figure 14: Stunted growth of KO myotubes.  Myotubes differentiated from myoblasts extracted from WT and KO 
mice were differentiated on collagen I treated and laminin treated Bioflex dishes. 
 
KO and WT myotubes adherent on either collagen I or laminin were subjected to mechanical 
strain with groups harvested immediately post strain (0h PS) or three hours post strain (3h PS).  KO and 
WT myotubes not subjected to strain were used as controls.  Western blot analysis was used to verify 
the lack of α7 integrin expression in KO myotubes (Figure 15).  Surprisingly, α7 integrin expression was 
5-fold higher in the presence of collagen compared to laminin in the absence of strain (P < .05) (Figure 
16).  At 0h post strain, α7 integrin expression increased (1.6 fold on collagen, and 2 fold on laminin) in 
myotubes irrespective of substrate compared to substrate-matched, unstrained controls.  At 3 hr post-
strain, α7 integrin expression was increased 1.8-fold in the presence of collagen and 3-fold in the 




Figure 15: Lack of α7 expression in myotubes differentiated from KO myoblasts.  Western blot analysis on 
myotubes shows an increase in α7 integrin expression with strain on both collagen and laminin substrates. There is 
no α7 integrin expression in KO myotubes. 
 
 
Figure 16: Quantification of α7 integrin expression with strain.  Western blotting quantification demonstrates 
higher basal levels of the α7 integrin on the collagen substrate than on the laminin substrate.  There was an 
increase in α7 integrin expression in response to strain on both laminin (3 fold at 3h, P < 0.05) and collagen (1.8 
fold at 3h, P < 0.05).   
 
 The hypertrophic signaling response to mechanical strain was then examined in the presence of 
collagen and laminin.  An increase in mTOR phosphorylation was not observed in WT myotubes at any 
time point on either substrate (Figure 17).  In contrast, p70 S6K phosphorylation was significantly 
26 
 
increased at 3 hr post-strain only in the presence of laminin (P < 0.05) (Figure 17)  Hypertrophic signaling 




Figure 17: The presence of the α7 integrin and laminin are important for the activation of p70 S6K in response to 
mechanical strain.  WT and KO myotubes were subjected to strain (18%, 1 Hz, 20 min) and phosphorylation of 







B) pMHCK-BX2 Transgenic Modification of Myotubes 
The rat sequence of the α7BX2 integrin was inserted into the pMHCK vector.  This plasmid DNA 
was transfected into WT myoblasts.   The empty vector (MHCK-CAT) was transfected into cells as a 
control.  The promoter (MHCK7) is turned on in the presence of myosin heavy chain and muscle creatine 
kinase.  In order to find the appropriate liposome mediated transfection reagent, transfections were 
performed using three reagents from different companies:  FuGENE HD, Lipofectamine, and Effectene.  
The vector does not have a reporter, so the presence of a 70k Da band on the α7 western blot, which is 
unique to the rat version of the α7 integrin, was used to verify a successful transfection.  
 All cells that were exposed to Effectene did not attach to the membrane resulting in the 
elimination of this group.  Myotubes either remained  unstrained to serve as a control, or were 
subjected to the same protocol previously outlined above.  Tubes were collected at 3 hr post-strain.  
Western blot analysis yielded a higher total α7 integrin expression in samples exposed to Lipofectamine, 
however the 70 kDa band was only observed in samples transfected using FuGENE HD (Figure 18).  
Despite a trend towards increased  α7 integrin protein presence in transfected myotubes compared to 
vector controls , significant increases were not detected (Figure 19). 
 
Figure 18: FuGENE HD results in successful transfection.  WT myotubes transfected with a Plasmid (P) or Empty 
Vector (V) were subject to strain (S) or left unstrained (R) as a control.  Presence of the 70 kDa band for α7 western 




Figure 19: Overexpression of α7 with transfection.  Quantification of western blotting performed for α7 integrin is 
shown.   
Hypertrophic signaling in response to strain and transfection was quantified ( Figure 20).  No 
significance was found in any of the groups.  However, there was a trend towards increased 
phosphorylation of p70 S6K (Thr389) (~30-40%) in transfected and/or strained myotubes compared to 
the unstrained myotubes transfected with the empty vector.  A similar trend was observed in the 
phosphorylation of p70 S6 Kinase (Thr421/Ser424)(~50-60%).  Phosphorylation of mTOR followed a 
trend of increase with strain compared to unstrained vector controls, as well as an increase in the 
unstrained plasmid group.  However, phosphorylation of mTOR was not elevated in the transfected 
myotubes following strain.  The downstream substrate of p70 S6K, S6, was not activated in response to 




Figure 20: Hypertrophic signaling response to strain in transfected myotubes.  Hypertrophic signaling was 
quantified via western blot analysis for plasmid or empty vector, strained or untrained myotubes.  No significance 
was found.  A) p70 S6 Kinase (Thr 389) signaling response to strain in α7 overexpressing myotubes B) p70 S6 Kinase 
(Thr421/Ser424) signaling response to strain in α7 overexpressing myotubes C) mTOR signaling response to strain 
in α7 overexpressing myotubes.   D) S6 signaling response to strain in α7 overexpressing myotubes. 
 
C) Strain and PI3K Inhibition (Wortmannin) With High Transfection Efficiency in Myotubes 
 
Previous work has shown increases in total protein in myotubes in response to strain 
independent of exogenous growth factors (Vandenburgh, 1979).  Further work has inhibited growth 
factor signaling using wortmannin which blocks the activation of PI3K (Hornberger, 2004; Miyazaki, 
2011).  In this experiment, myotubes were incubated with wortmannin in order to ensure any possible 
amplifications of hypertrophic signaling in transfected samples were independent of paracrine or 
autocrine signaling.  All myotubes were strained, and harvested 3h post strain.   Half received 
wortmannin while half did not.  In order to determine whether the wortmannin affected growth factor 
signaling, a western blot was performed to assess phosphorylation of AKT.  As shown in Figure 21, 
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phosphorylation of AKT and S6 was reduced by ~60 % with an overnight incubation of wortmannin with 
significance (P<.05) being found in the reductions of S6.  Additionally there was no increase in AKT or S6 
activation with strain in either group. 
 
Figure 21: Reduction in AKT and S6 signaling demonstrates wortmannin is Effective.  AKT and S6 signaling was 
quantified via western blot 3h post strain in myotubes either transfected with the empty vector or plasmid and in 
the absence or presence of wortmannin. (* P<.05) 
 
 α7 Integrin expression (Figure 22) was markedly and significantly increased 8.6 fold (P < 0.05) 
with transfection for the groups which did not receive wortmannin.  Unfortunately, α7 integrin 
expression did not remain stable in the presence of wortmannin, with wortmannin increasing α7 
integrin expression in myotubes transfected with the vector control and decreasing α7 integrin 
expression in myotubes transfected with the plasmid none of which were found to be statistically 




Figure 22: α7 Integrin expression with transfection and wortmannin following strain.  α7 integrin expression was 
quantified via western blot 3h post-strain in myotubes either transfected with the empty vector or plasmid and in 
the absence or presence of wortmannin.   
 
Interestingly, amplification of the phosphorylation of mTOR, p70 S6K (Thr389, Thr421), and S6 
was not observed in transfected myotubes following strain compared to controls despite the 8-fold 




Figure 23: Hypertrophic signaling response to strain and wortmannin in transfected myotubes.  Hypertrophic 
signaling was quantified via western blot 3h post strain in myotubes either transfected with the plasmid or empty 
vector, after an overnight incubation in wortmannin.  A) p70 S6 Kinase (Thr389) signaling response to strain, with 
transfection and wortmannin.  B) p70 S6 Kinase (Thr421/Ser424) signaling response to strain, with transfection and 
wortmannin. C) mTOR signaling response to strain, with transfection and wortmannin. 
 
D) Wortmannin and Transfection: Rest vs. Strain 
In order to get a better understanding of the effect of wortmannin on α7 integrin expression, 
the previous experiment was repeated with unstrained controls.  The transfection efficiency observed in 
this experiment was much lower than in the previous experiment (Figure 24).  For samples negative for 
wortmannin, α7 integrin expression (Figure 24) was only slightly increased in plasmid transfected 
myotubes compared to vector transfected myotubes in the absence of strain (rest samples).  Similarly, 
α7 integrin expression was not significantly increased in plasmid transfected myotubes compared to 
vector transfected myotubes following strain.  Consistent with the previous experiment, wortmannin 
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altered α7 integrin expression in a manner that resulted in both the upregulation and downregulation of 
the protein.    
 
Figure 24: α7 Integrin expression with Transfection and Wortmannin.  α7 integrin expression was quantified 3h 
post strain, with transfection of the plasmid or empty vector, and with or without an overnight incubation in 
wortmannin.  Transfection efficiency was found to be low.   
 
Activation of p70 S6K (Thr389, Thr421/Ser424) was not observed either in response to strain in 
vector control, nor in response to low transfection of the α7 integrin.    There was a significant (P < 0.05) 




Figure 25: Signaling response to strain with transfection and wortmannin.  Hypertrophic signaling was quantified 
3h post strain, with transfection of the plasmid or empty vector, and with or without an overnight incubation in 
wortmannin.  A) p70 S6K (Thr389) signaling response to strain, with transfection and wortmannin.  B) p70 S6K 
(Thr421/Ser424) signaling response to strain, with transfection and wortmannin. C) mTOR signaling response to 
strain, with transfection and wortmannin.  D) S6 signaling response to strain, with Transfection and Wortmannin. 
 
E) Laminin-111 and the α7 Integrin 
 
Previous studies have demonstrated that injections of laminin-111 can elicit an increase in α7 
integrin expression in mice (Rooney, 2009).  As a preliminary step to establish whether or not laminin-
111 could be used as a model of overexpressing the α7 integrin in myotubes, immunocytochemistry for 
α7 integrin was performed after an overnight incubation in different concentrations of laminin-111 
(figure 26).  There was no visible difference in α7 integrin expression until the concentration reached 
100nM, and there was a vivid difference in α7 expression with 200nM laminin-111 as compared to the 




Figure 26: α7 Integrin expression after an overnight incubation in laminin-111.  Myotubes (C2C12) were incubated 
overnight in varying concentrations of laminin-111; 0nM, 25nM, 50nM, 100nM and 200nM.   
 
 Upon verification that there were increases in α7 integrin expression with an overnight 
incubation of laminin-111 using ICC, myotubes differentiated from C2C12 cells and grown on the 
collagen I substrate were incubated overnight in 0 nM, 50 nM, or 100 nM of laminin-111 and subjected 
to mechanical strain.  Examination of the Flexcell dishes post strain revealed de-attachment of the 
myotubes had occurred at some point during strain.  α7 integrin expression and signaling changes were 
still analyzed by western blot, but duration of strain prior to detachment is unknown.  When quantified 
via western blot, α7 integrin expression (figure 27) was found to be slightly increased with increasing 
concentrations of laminin-111.  There was a 20% increase in α7 expression with 100nM of laminin-111 




Figure 27: α7 Integrin expression in response to strain and an overnight incubation in laminin-111.  Myotubes 
(C2C12) were incubated overnight in 0 nM, 50 nM, or 100 nM of laminin-111 and subject to 20 minutes of strain.  
Strained myotubes detached from the bioflex membrane during strain.  α7 integrin expression increased as the 
concentration of laminin-111 increased. 
 
Figure 28: Hypertrophic signaling response to strain and an overnight incubation in laminin-111.  Myotubes 
(C2C12) were incubated overnight in 0 nM, 50 nM, or 100 nM of laminin-111 and subject to 20 minutes of strain.  












A) Mechanical Strain 
 
 Previous work in the Molecular Muscle Physiology Lab has delineated a role for the α7 integrin 
in muscle hypertrophy.  However, due to the complexity of the intramuscular environment it is difficult 
to elucidate the precise mechanism responsible for this observation in vivo.  While hypertrophic 
signaling molecules were activated to a greater extent in transgenic mice overexpressing the α7 integrin 
as compared to wild type animals, the reason for enhancement of growth remains unknown (Zou, 
2011).  Increased adhesion of the fibers to the ECM created by transgenic overexpression of the α7 
integrin can create an environment conducive to growth by limiting the amount of damage and 
inflammation accumulated by eccentric exercise(Boppart, 2006; Boppart, 2008; Leuders, 2011; Zou, 
2011).  Alternatively, the α7 integrin could be an intrinsic regulator hypertrophic signaling via 
mechanotransduction. 
 The purpose of this study was to determine whether the α7 integrin is, or is not an intrinsic 
regulator of hypertrophic signaling, and because of the complexity of the intramuscular environment as 
mentioned above, an in vivo model is not suitable to answer this question.  Both primary cells and 
C2C12 cells were experimented with as a means to form myotubes, which is an in vitro model of muscle 
(Vandenburgh, 1979).  In order to replicate mechanical stimulation in vivo, the Flexcell System (FX-4000) 
was used.  Previous work Hornberger et al. had already established that 15% strain was sufficient to 
elicit a hypertrophic signaling response in cultured myotubes with equibiaxial strain, but not with 
uniaxial strain (Hornberger, 2004).  The strain protocol used for the experiments in this study was based 
on these previous studies, with the idea that signaling responses would be directly related with α7 
integrin expression, as observed in vivo.  In experiments performed for our project, however, 
statistically significant increases in signaling with strain were extremely rare, occurring in only one trial 
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as observed in Figure 17.  The experiments were continued using this protocol, hoping that upon 
overexpression of the α7 integrin via transient transfection, there would be a statistically significant 
enhancement of the signaling response to support our hypothesis.   However, mechanical strain did not 
consistently increase hypertrophic signaling even in the absence of α7 integrin overexpression, which is 
exemplified in Figures 7, 12A & 12B.   
 Future experiments of this nature call for an optimization of the strain protocol for our lab in 
order to establish consistent, and statistically significant increases in signaling with strain.  Only after this 
optimization should transient overexpression of the α7 integrin be re-attempted, and strain experiments 
performed.  Parameters of strain, such as time points of harvest, duration of strain, as well as waveform 
of strain and frequency are all to be compared to one another in an attempt to find a protocol which 
yields the greatest hypertrophic response of the myotubes to strain.  Direction of strain is to be re-
assessed, comparing biaxial and uniaxial strain similar to T.A. Hornberger’s experiments in 2004, as well 
as performing a uniaxial pre-strain on differentiating myoblasts in order to force alignment of tubes 
perpendicular to strain; which has been performed in the study “Uniaxial Cyclic Strain Drives Assembly 
and Differentiation of Skeletal Myocytes” (Pennisi, 2011).  Once aligned tubes are formed, strain will be 
transmitted parallel to these aligned myotubes, and the hypertrophic response examined.   
Because the laminin content of the pre-treated plates available through Flexcell International is 
a proprietary blend, it is not possible to know the concentrations of laminin, nor which isoforms are 
present.  In order to better control substrate in future experiments, myotubes can be grown on PDMS 
hydrogels fabricated with an elastic modulus of 12 kPa used to mimic the stiffness of muscle, along with 
the addition of various concentrations of laminin (Gilbert, 2010).  Signaling molecules such as JNK and 
p38  which are indicative of strain sensed by tissues and cells will also be analyzed by western blot 
(Boppart 2001, Boppart, 2006).  
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B) α7 Integrin Therapy 
 
 The α7 integrin has been shown previously to alleviate damage caused by muscular dystrophy, 
and the lack of the α7 integrin in muscle results in increased muscle damage and a muscular dystrophy 
phenotype (Mayer, 1997; Liu, 2011; Rooney, 2009).  Increased α7 integrin through transgenic 
overexpression in mice has shown increased muscular growth, myofibrillar content, and increases in 
hypertrophic signaling (Leuders, 2011; Zou, 2011).  Global gene profiles are unaltered in transgenic 
models with overexpression of the α7 integrin, and no toxic effects have been observed.  Additionally 
myoblasts with elevated α7 integrin expression have been shown to proliferate faster, have better 
resistance to apoptosis, and adhere better laminin as compared to myoblasts with normal levels of α7, 
without impacting the ability for the cells to differentiate normally (Liu, 2011).  In applying these 
established benefits of the α7 integrin towards alleviating disease or age related myopathies in humans, 
a safe method of manipulating the α7 integrin is necessary before this can become a therapy.  Laminin 
has been found to be a positive regulator of α7 integrin expression and it has been shown that injections 
of laminin-111 increases α7 integrin expression in vivo (Burkin, 1999; Rooney, 2009). 
 In this study, addition of laminin-111 was found to increase α7 integrin expression in C2C12 
myotubes grown on collagen I-coated Bioflex membranes (Figure 14).  Despite the ability to 
conditionally induce α7 integrin expression, myotubes incubated in laminin-111 detached from the 
membrane during mechanical strain.  This was likely due to preferential binding of the myotubes to  
laminin-111 in suspension which was not adherent to the Bioflex membrane .  In future trials of this 
experiment, laminin-111 will be incorporated into PDMS membranes that will be attached to the Bioflex 
membranes.  This will ensure transient upregulation of the integrin and subsequent ability to strain the 




C) Focusing the Model after Preliminary Results 
 
 Initial experiments started quite broad, examining α7 integrin expression and hypertrophic 
signaling 0 h post strain as well as 3 h post strain.  The 0 h post strain time point was chosen to be 
consistent with experiments by Hornberger et al. (Hornberger, 2004).  The 3 h time point chosen to 
examine whether the signaling changes persisted or even increased further, which was found to be the 
case in a study looking at signaling in vivo after downhill running (Boppart, 2006).  Both the collagen I 
and laminin substrates were used initially as well.  Collagen I was the substrate used by Hornberger et 
al., and we decided to use laminin as well because it is the binding partner for the α7 integrin (Collo, 
1993; Hornberger, 2004; Schober, 2000).  Although Hornberger et al. used C2C12 cells for his 
experiments, primary myoblasts were chosen for the beginning experiments because this allowed us to 
create KO myotubes.  After this model was found to be insufficient, the decision to use C2C12 cells was 
made for a few experiments due to concern that the plating method used to obtain the primary 
myoblasts can result in a mixed cell population.  After working with the C2C12 cells it was found that 
prior to differentiation, myoblasts rapidly proliferated and were prone to extreme overconfluence .  This 
resulted in the presence of many undifferentiated myoblasts as well as increased risk for detachment of 
the C2C12 myotubes during strain.  Additionally, the literature suggests that C2C12 myotubes are an 
insufficient compared to primary myotubes for the study of muscle physiology.  C2C12 myotubes have 
been found to exhibit abnormal Ca2+
Preliminary experiments demonstrated higher basal α7 integrin expression on collagen I than on 
laminin (Figure 16).  This is likely due to upregulation of α7 integrin protein on collagen in response to 
decreased binding.  Because the binding partner for α7 is laminin, there is higher binding on this 
substrate, and in order to increase the chance for α7 to bind to any laminin secreted by the cells, total 
protein was increased on collagen.  There was also an increase in α7 integrin expression in response to 
 signaling and form with a heterogeneous distribution of 
sarcoplasmic reticulum (Lorenzon, 2002). 
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strain, reaching the highest increase 3 h post strain on both substrates.  Because it is unlikely that such 
rapid increases in protein would occur it is hypothesized that mechanical strain-induced activation of the 
α7 integrin and increase in binding to laminin, yields a change in integrin conformation which may allow 
for enhancement of primary antibody binding.  Thus, the fold increase in α7 integrin expression with 
strain would be reflective of an increase in α7 integrin activation.  In support of this hypothesis, the 
highest increase in α7 was observed 3 h post strain on the laminin substrate, and this was the only time 
point found to have a statistically significant increase in phosphor p70 S6 Kinase (Thr 389).  Because of 
these results future experiments were performed on laminin and myotubes were harvested 3 h post 
strain. 
D) α7 Integrin KO Myotubes as a Model 
 
 The initial experimental design to address the hypothesis was to simply have myotubes that 
express the α7 integrin, and to have myotubes that do not.  If there was no signaling response in α7 KO 
myotubes, or a significantly blunted response, then the hypothesis would of course be accepted.  In 
order to achieve this, myoblasts extracted from α7 integrin KO mice, as well as from WT mice were 
expanded on the bioflex membrane and differentiated into myotubes.  There was absolutely no 
signaling response to strain in KO myotubes, as seen in Figure 17.  However as observed in Figure 14, KO 
myoblasts did not form myotubes with normal morphology, instead forming stunted as compared to WT 
myotubes.  It was determined that this model was unsuitable to address the hypothesis due to the 
formation of stunted myotubes from KO myoblasts .   
The α7 integrin expression is upregulated with differentiation and binding of the α7 integrin to 
laminin and helps with myoblast migration during differentiation (Collo, 1993).  KO myotubes could have 
been malformed due to the possibility that the α7 integrin is essential for differentiation of myoblasts 
into myotubes.  The α7 integrin is important for actin stabilization at the Z-bands, and the absence of 
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this protein leads to a mild and progressive form of dystrophy (Mayer, 1997).  Because of this unhealthy 
intramuscular environment, there are likely much more fibroblasts in the muscle, and a possible 
depletion of myoblasts as seen with muscular dystrophy (Jejurikar, 2003).  This can result in the retrieval 
of more fibroblasts and less myoblasts during extraction, increasing the possibility of fibroblast 
contamination in the KO primary myoblast cultures obtained using the plating method.  In order to 
prevent this address this concern, extracted myoblasts should be sorted by FACS prior to expansion in 
culture. 
E) Overexpression of α7 Integrin Using the Transient Transfection Model 
 
 After it became apparent that the simplistic approach of comparing the hypertrophic response 
of mechanically strained WT myotubes to the response of KO myotubes was problematic due to the 
stunted morphology, overexpression of the α7 integrin via transient transfection was performed.  WT 
Primary myoblasts were transfected with either a plasmid for rat α7 integrin (pMHCK-BX2), or the empty 
vector (MHCK-CAT), and subjected to strain.  This technique had never before been performed in the 
Molecular Muscle Physiology Lab, requiring trial and error to find an appropriate reagent.  In searching 
the literature for protocols and previously used reagents, it was determined that transfection on 
terminally differentiated cells yielded a very low efficiency, and transfection on suspended cells yielded 
a very high transfection efficiency.  This required the transfection of the myoblasts during plating onto 
the bioflex membrane, and due to the results from KO myotubes, the issue of α7 expression affecting 
differentiation was considered.  The worry of cells overexpressing α7 integrin with transfection, and 
thus affecting differentiation, was sequestered by the promoter of the vector.   This promoter allows the 
transgene to be expressed only in the presence of muscle creatine kinase and myosin heavy chain, with 
the result being overexpression of α7 integrin only occurred after myotubes were mature. 
43 
 
The first obstacle with this model was determining transfection efficiency due to the lack of a 
reporter in the vector.  Fortunately, the rat α7 integrin protein sequence contains a unique proteolytic 
cleavage site compared to mouse α7 integrin that allows for the detection of a 70 kD protein product by 
SDS-PAGE.  (Liu, 2011). As observed in Figure 18, this was used to determine whether transfection 
worked, or did not work.  Only comparisons of α7 integrin expression in transfected myotubes as 
compared to the control could be used to determine the extent to which the transfection worked.  
Recent access to a GFP plasmid which will allow us to co-transfect cells with GFP and the pMHCK-BX2 
plasmid can be employed for future experiments.  With the assumption that efficiency is the same for 
both plasmids, transfection efficiency can be verified and compared via fluorescence microscopy. 
While transfection was successful with the FUGENE HD reagent, only one experiment yielded 
statistically significant increases in α7 expression with transfection of the plasmid as compared to the 
control (Figure 22).  This transfection resulted in a similar fold increase in α7 integrin expression as is 
seen in vivo with the α7 transgenic mice (8-fold).  When looking at the signaling changes observed in Zou 
et al. with this level of α7 overexpression, phosphorylation of mTOR was found to increase 50% as 
compared to WT controls, and phosphorylation of p70 S6K was found to increase 30%.  Thus, we did not 
expect results to be much greater in magnitude than these.  As seen in Figure 23, the hypertrophic 
signaling response in strained, transfected myotubes as compared to strained, control myotubes 
trended towards the same level of increases, however statistical significance was not found, which could 
potentially be due to the small sample size employed.  Alternatively, insufficient b subunit availability 
may also limit α7 integrin function.  Thus, concomitant overexpression of β1D along with α7 integrin 
may allow for increased translocation of α7 integrin to the membrane and increase the potential for a 




F) Inhibition of Growth Factor Signaling 
 
 Eighteen hours prior to straining myotubes, cell media was changed to growth factor depleted 
media.  Despite the elimination of growth factors the potential for growth factor induced increases in 
hypertrophic signaling were still possible through autocrine and paracrine signaling.  With strain there is 
a release of growth factors in from the muscle which can be released from muscle fibers themselves or 
other cell types in muscle such as mesenchymal stem cells (MSCs) (Adams, 2004; Goldspink, 2002; Xu, 
2009).  As mentioned previously, the plating method used to obtain the primary myoblasts is not a 
flawless method, which can result in a mixed population of cells.  In order to assess 
mechanotransduction, wortmannin was used to inhibit PI3K, eliminating growth factor activation of 
hypertrophic signaling. 
When protein was analyzed via western blot it was found that wortmannin had an effect on α7 
integrin expression (Figure 22).  For this experiment, only strained myotubes were compared to each 
other with and without transfection, and with and without wortmannin.  In order to get a better 
understanding of how wortmannin was regulating protein expression and activation, the experiment 
was repeated and unstrained groups were included.  Unfortunately, this experiment resulted in a very 
low increase in α7 integrin expression with transfection despite the appearance of a clear band at 70 
kDa in transfected samples (Figure 24).  Wortmannin again affected α7 integrin expression; however the 
effects were not consistent with what was observed in the previous experiment.  Additionally, there was 
no effect of strain on hypertrophic signaling as compared to unstrained controls (Figure 25) indicating 






 The results of this study are inconclusive.  Some of the performed experiments demonstrate 
trends towards the involvement in the α7 integrin in mechanotransduction.  However, no statistically 
significant differences were observed to suggest a role for the integrin in strain-induced muscle growth. 
Results from PI3K inhibition were inconsistent and did not support the hypothesis.  While this study 
yielded inconclusive results, the α7 integrin is still extremely important both for muscle repair and 
growth.  As mentioned in the Discussion, further optimization of the experimental models used must be 
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APPENDIX: Experimental Protocols 
A) Procedure: Thawing, Culture, Subculture, Differentiation & Introduction of C2C12 Cell Lines 
Thawing (C2C12 Cells)  
1) Remove from -80o
2) Immerse cryogen vial containing cells (stored in DMSO, -80
C freezer and place in bucket on dry ice 
oC) and warm DMEM (+FBS, 
Glutamine, CEE, and PSK) in 37o
3) Turn on flow hood 
C water bath 
4) Pipette 1mL Thawed Cells in 9mL DMEM growth media in a 10mL capped tube 
5) Centrifuge 5 min  
6) Aspirate supernatant and add 6mL DMEM growth media to the cell pellet 
7) Break the pellet to resuspend the cells and split 3 mL onto each plate 
a. If using 60mm plates keep media at 3-5mL 
b. If using 100mm plates add 7mL DMEM Growth Media ( total 10mL) 
8) Label dish with name & date and passage and place in incubator 
9) Spray hood with 75% ETOH  
Splitting Cells 
1) Warm DMEM and trypsin in water bath at 37oC 
2) Wash cells with 3mL 1X PBS 
3) Add 1mL trypsin, incubate in CO2 incubator for 5 min.  Look under microscope for detachment 
4) Add 1 mL DMEM to neutralize trypsin 
5) Collect cells into 10mL tube and centrifuge for 5 min 
6) Aspirate supernatant 
7) Resuspend cells in 5mLs of DMEM Growth Media 
8) Divide onto plates 
Freezing Cells 
1) Follow steps “Splitting Cells” 1-6  
2) Resuspend in 6mL of freeze media. 
3) Add 1 mL/cryogen vial, (18 vials for 3 plates) 
4) Label vials DMEM, 20% FCS, C2C12
Counting Cells 
, date, passages 
1) Add 10uL of cells to hemocytometer  
2) Count 5 fields on both sides of the meter 
3) Equation:   
a.  Average (Cells counted on each side ) =  (Side 1+Side 2)/2 
b. (Cells counted)/5 cells/mL X 10mLs = Y Cells/mL 
c. 1 million cells for 100mm diameter plate 




1) DMEM Growth Media for 50mL 
a. 40 mL DMEM 50/50  
b. FBS 10 mL 
c. rFGF .005 mL 
d. PSK .5 mL 
2) Differentiation Medium For 50mLs 
a. DMEM – 49 mL 
b. Horse Serum – 1 mL 
c. PSK – .5 mL 
3) Freeze Medium 
a. DMEM Growth Medium (whatever the cells are grown in) 
b. DMSO (10%) 
Amount of Media for each plate 
 35mm Plates: 3mL 
 60mm Plates: 5mL 
 100mm Plates: 10mL 
 Flexcell Plates (per well) 
  When Growing: 2.5mL 














B) Extraction of Protein from cells: 
 
1) Protein is extracted at 4o
2) Put 200 µl of buffer in each tube, and vortex until pellet is in solution 
C in 100-200 µl of RIPA buffer. 
3) Place on inverter in cold room for 30 minutes 
4) Micro centrifuge at 14,000rpm for 2-5 minutes 
5) Collect supernatant in a 1.5 µl micro centrifuge tube on ice (this is your extracted sample) 
6) Repeat steps 2 through 5, using 100 µl of buffer (step 2) 
7) Make aliquots if necessary, and save 2 µl of each sample for the Bradford assay. 
8) Snap Freeze in liquid nitrogen and store in -80 
For 100 mL of RIPA buffer: 
- To 50 mL ddH20 add: 
- 790 mg Tris-Base 
- 900 mg NaCL 
- pH to 7.4 with HCl 
- 1 mL NP-40 (or 10 mL of 10% NP-40) 
- 0.5 g Sodium Deoxycholate (or 5 mL of 10% sodium deoxycholate) 
- 0.1 g SDS Powder (or 1 mL of 10% SDS sol’n) 
- 0.0174 g PMSF 
- Fill to 100 mL with ddH20 
- Store at 4oC for 6 months or aliquot and store at -20oC long term. 












C) α7β1 Transgene Plasmid Extraction from Transformed DH5α Bacteria 
Day 1: Seeding plates from frozen bacteria 
1) Obtain vials containing bacteria (DH5α Amp-R) from -80o
2) Remove Luria Broth (LB) + Ampicillin (AP) treated agar plates from the fridge and let acclimate 
to room temperature with the agar side of the plate facing upwards, letting the condensation 
fall onto the lid.  Label the plates on the agar side of the plate (not the lid). 
C  - Plasmid with transgene (pMHCK-
BX2), and Plasmid control (MHCK-CAT).  Thaw on ice. 
3) Turn on the Bunsen Burner (Flame should be blue. 
4) Shake the plates (agar side, and lid facing downwards) in the vicinity of the flame to remove 
excess condensation. 
5) Using the Bunsen Burner heat Loop Wire until it is visibly orange, and cool against the LB + AP 
treated agar plate.  Be careful to lift the lid of the plate only as high as necessary to fit the loop 
wire between the lid and the plate. 
6) Vortex the vial of bacteria and rinse with ethanol.  Only open the vial in the vicinity of the flame. 
7) Dip the loop wire into the vial of bacteria, and streak onto the plate (streak 1).  When streaking 
begin on the outer edge of the plate and streak towards the center, being careful not to cross 
back up across a streak. 
8) Repeat step 2, and streak twice over streak 1, and form a new streak in a different location on 
the plate(streak 2).  After the second pass of streak 2 over streak 1, do not allow the loop to 
come into contact with streak 1 a third time. 
9) Repeat step 3, this time forming a 3rd
10) Use parafilm or tape to secure the lid onto the plate, and place in the warm bacteria culture 
room on the third floor with the agar side of the plate facing up. 
 streak from streak 2. 
11) Allow the bacteria to grow over night, and place at room temperature the following morning. 
Day 2: Inoculation liquid media with fresh bacteria 
1) Obtain plates streaked with Plasmid containing bacteria and plasmid control bacteria, as well as 
two labeled round bottom bacteria culture falcon tubes. 
2) Add 3ml of LB with 100mg/ml AP (25 ml LB + 50µl AP) into the falcon tubes. 
3) Using  a sterilized yellow pipette tip, pick an isolated colony, and drop the tip into the tube. 
4) Place the caps on the falcon tubes, and put the tubes in the shaker in the warm bacteria culture 
room on the third floor. 
5) Allow the bacteria to grow over night.  Place in fridge the following morning 
6) Do not discard the plates at this juncture.  Instead wrap them in parafilm to prevent drying, and 
place in the fridge. 
Day 3: Extraction of plasmids, and determination of concentration using a gel (taken From QIAprep Spin 
Miniprep Kit) 
1) Using the microwave for 2 minutes, heat water to 50oC to be used in step 11. 
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2) In the vicinity of a flame, pour the bacteria culture into a 2ml tube.  Centrifuge 3 minutes @ 
9,000 RPM.  Decant the supernatant and repeat until all of the culture is used. 
3) Resuspend pelleted bacterial cells in 250µl Buffer P1 (from 4o
4) Add 250 µl  Buffer P2 and mix thoroughly by inverting the tube 4-6 times. (If using LyseBlue 
reagent, solution turns blue).  Let incubate until there is an increase in viscosity.  
C and return after use) and 
transfer to a micro centrifuge tube. 
5) Add 350 µl  Buffer N3 and mix immediately and thoroughly by inverting the tube 4-6 times. (If 
using LyseBlue reagent, solution turns colorless). 
6) Centrifuge for 10 min at 13,000 rpm in a table-top micro centrifuge. 
7) Apply the supernatant (from step 6) to the QIAprep spin column by decanting or pipetting. 
8) Centrifuge for 30-60s.  Discard the flow-through 
9) Recommended: Wash the QIAprep spin column by adding .5ml Buffer PB and centrifuging for 
30-60s.  Discard the flow through.  (This step is only required when using endA+ or other 
bacteria strains with high nuclease activity or carbohydrate content) 
10) Wash QIAprep spin column by adding .75ml Buffer PE and centrifuging for 30-60 s. 
11) Discard the flow-through, and centrifuge for an additional 1 min to remove residual wash buffer.  
After removing the spin column, dab on a Kim Wipe to ensure it is dry.  
12) To elute DNA, place the QIAprep column in a clean 1.5ml micro centrifuge tube.  Add 50ul water 
to the center of each QIAprep spin column, let stand for 3 min, and centrifuge for 1 min. 
Identifying the Concentration of Plasmid after Extraction: 
1) Turn on the computer and the plate reader.  Open Gen5 software 
2) Select Read now  Take 3  Nucleic Acid 
3) Set up the parameters in the software, Plate, microspots, dsDNA 
4) Set up the plate layout: Blank, Sample, Empty 
5) Blank in the reagent that the DNA is diluted in 
6) Add 2ul of each sample in duplicate 
7) Slowly close the cover of the DNA plate 
8) Match A1 with A1 when loading the plate into the plate reader 
9) Click read 
10) To clean – dab with a Kim wipe (DO NOT USE LIQUID, DO NOT RUB).  Repeat 2x for the cover 
and the microspots 














D) FuGENE HD  on Suspended Primary Cells 
COMPONENT X VOLUME (PER WELL) = # WELLS 
TUBE 1 
TOTAL VOLUME 
          
Plasmid: 4 µL (.5µG) X _____ = _____ 
Fugene6 6 µl X _____ = _____ 
SFM:   90 µL X _____ = _____ 




1) Grow Primary cells on 10cm dishes over night 
2) Trypsinize Cells from the 10cm dish and re-plate ~150k-200k cells per well on a 6 well Flexcell 
dish. 
a. Resuspend in .8ml SFM media per well 
3) Prepare Plasmid/Transfection Mixture (incubations at room temperature): 
a. FuGENE HD: Add FuGENE reagent in SFM media.  Mix and incubate 5 minutes.  Add 
Plasmid, mix and incubate 15 minutes. 
4) Add the transfection solution to the existing media in the wells of the plate 
5) Incubate the cells with the transfection solution 
a. Incubate at 37o
6) 17-24 hours later change to differentiation medium. 
C for 5 hr, then add 1mL growth media.  Allow to incubate for an 







E) ICC of Alpha 7 
1 slides (4 chambers) - 800 µl/slide  
Immunocytochemistry – Alpha 7 
Procedure Directions 
Section Preparation 6 µm sections placed on the slide;  
Allow frozen slides to thaw and dry 
Fix Place all slides in 
-30 minutes (in freezer) 
(4% Paraformaldehyde  
 
Wash & Rehydrate 1x DPBS - 5 min, 3 times 
(3 ml 1x DPBS) 
Block 10% HS (in 1x DPBS) – 1 hr 




Primary Antibody α7B 1:500 in 1% HS (140µl HS/ 13,860µl DPBS) - 60 min 
1.6 µl α7B/ 800 µl 1% HS 
*Don’t Put On Negative Control - Leave wash on from last step* 
Wash 1% HS (in 1x DPBS) - 5 min, 3 times 
 Secondary Antibody *I n Dar k* FITC anti-Rabbit 1:250 dilution in 1% HS - 60 min 
4 µl TRITC/ .996 ml of 1% HS (place slides in drawer) 
Wash 1% HS (in 1x DPBS) - 5 min, 3 times (DAPI at wash 2) 
DAPI  
Coverslip Remove Chamber using Key 
Add Vecta shield SPARINGLY 
Apply coverslip DO NOT SLIDE COVERSLIP (cells will fall off) 
Seal with nail polish 











F)  Test Phospho-mTOR (289kda) and p70 S6K (70kda) western blot 
PROCEDURE DETAILS COMMENTS 




Prepare Samples Add 31mg DTT into 4xLB 




Electrophoresis Start at __100V
Run ___
_30 min__ 
200__v for __30___min 
 





(IN COLD ROOM) 
___min  
Ponceau S staining 1min 
Rinse membrane with ddH2
Take pictures 
O 3X 
Rinse membrane with ddH2
 
O 2X 
Block 5%  BSA + 400ul NaN3





Cut Membrane into 2 parts at  
150kda site 
(2nd band from top of the ladder) 
 
Antibody Information Primary Antibody 
Phospho-mTOR (Ser 2448) Rabbit Ab 
Phospho-p70 S6K (Thr 389) Rabbit 
Ab 
1:1000_
 8ml 5% BSA (from previous step) 
+ 12ml TBST 









Secondary Antibody Antibody Information 




Made with Powder (1g non fat milk 














G) Western Blot - α7B 
3 Bands - 120kDa 
PROCEDURE DETAILS COMMENTS 
Gels 3.5% Stacking 
8.0% Running 
 
Prepare Samples No DTT 
Do not boil samples 
 
Electrophoresis 100V for 30 min 
200 for 30 min 
 
Transfer 100V for 30 min  
(IN COLD ROOM) 
Ponceau S staining 1min 
Rinse membrane with ddH2O 3X 
Take pictures 
Rinse membrane with ddH2O 2X 
 
Block 5% Non-fat milk + 400ml NaN3 
2.0g milk + 40ml TBST 
Incubate overnight @ 4℃ 
 
CDB347 1:1000 (in 2% milk) Primary Antibody 
Take 8.0 ml 5% milk from previous step 
Add 12 ml TBST 
Incubate 60 min 
 
Rinse 3x’s in 0.1% TBST, 5 min  
 
Secondary Antibody Anti-Rabbit HRP 1:10000 (in 2.5% 
milk) 
0.5g milk/ 20ml TBST 






Rinse 4x’s in 0.1% TBST, 10 min  
 
 
